Logo
x

Search

Subscribe Now

Astrazeneca

Health Canada Approves AstraZeneca’s Imfinzi to Treat Limited-Stage Small Cell Lung Cancer (LS-SCLC)

Health Canada Approves AstraZeneca’s Imfinzi to Treat Limited-Stage Small Cell Lung Cancer (LS-SCLC)

  • April 11, 2025
AstraZeneca and Daiichi Sankyo Receive the EC’s Approval for Datroway to Treat HR+/HER2- Breast Cancer

AstraZeneca and Daiichi Sankyo Receive the EC’s Approval for Datroway to Treat HR+/HER2- Breast Cancer

  • April 10, 2025
AstraZeneca Reports the EC’s Approval of Imfinzi Regimen as Perioperative Treatment of NSCLC

AstraZeneca Reports the EC’s Approval of Imfinzi Regimen as Perioperative Treatment of NSCLC

  • April 4, 2025
AstraZeneca Reports the Data from PURSUIT P-IIb Study Evaluating AZD0780

AstraZeneca Reports the Data from PURSUIT P-IIb Study Evaluating AZD0780

  • April 1, 2025
AstraZeneca’s Calquence (Acalabrutinib) Plus Chemoimmunotherapy Receives the CHMP’s Positive Opinion for 1L Mantle Cell Lymphoma (MCL)

AstraZeneca’s Calquence (Acalabrutinib) Plus Chemoimmunotherapy Receives the CHMP’s Positive Opinion for 1L Mantle Cell Lymphoma (...

  • March 31, 2025
AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025

AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025

  • March 25, 2025
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.